MedTrace Logo

Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells

NCT05167188 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-05-24

No results posted yet for this study

Summary

Spontaneous, multicenter, prospective, non-pharmacological study. At the diagnosis of acute or chronic GvHD after HSCT, bone marrow cells will be analysed for MSC content and properties. Bone marrow aspirate will be performed according to usual clinical practise

Conditions

  • Graft Vs Host Disease

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna

    lead OTHER

Eligibility

Min Age
6 Months
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-14
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05167188 on ClinicalTrials.gov